Article
30 Mar 2026
Overbreadth Gets A Lifeguard: The FCA Blows The Whistle In ProSlide v. WhiteWater
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in Canada
AUTHORS CONTENT
Article
29 Dec 2025
Les lignes directrices définitives du CEPMB sur le prix des médicaments brevetés entrent en vigueur le 1er janvier 2026 : ce que cela signifie pour les entreprises pharmaceutiques innovantes
Article
23 Dec 2025
Final Patented Medicines Pricing Guidelines From The PMPRB Take Effect On January 1, 2026: What This Means For Innovative Pharma
Article
19 Dec 2025
Patent Infringement Damages Can Extend To Products Beyond Scope Of Claims
Article
21 Nov 2025
Dealing A New Hand: Federal Court Gives Card Game Patent A Second Chance
Article
06 Nov 2025
Streamlined Biosimilar Approvals: What The End Of Biosimilar Phase III Trials Means For Innovative Pharmaceutical Patent Holders
Article
28 Oct 2025
What The Frack? FCA Clarifies Claim Construction And Double Patenting
Article
04 Aug 2025
Aperçu du rapport statistique 2024-2025 de Santé Canada sur le régime canadien des brevets pharmaceutiques
Article
31 Jul 2025
Insights From Health Canada's 2024–2025 Statistical Report On Canadian Pharmaceutical Patent Regime
Article
20 Jun 2025
Biosimilar Update: Health Canada Reconsiders Requirement For Comparative Clinical Trials
Article
05 Jun 2025
Patent Re-Examination Board Decision Does Not Preclude Patent Validity Challenge In Court
Article
12 Feb 2025
Federal Court Re-balances Due Care Assessment For Reinstating Abandoned Patent Applications
Article
23 Dec 2024
Novel Biosimilar Anti-Trust Complaint Involving Janssen's STELARA (Ustekinumab) Dismissed By The Canadian Competition Tribunal
Article
19 Dec 2024
Federal Court Of Appeal: Patented Medicine Prices Review Board "Crashed" Through "Guardrails" In Attempt To Regulate Unpatented Medicine
Article
04 Oct 2024
The Diaper Wars, Episode 2: FCA Finds US Parent Company Liable For Patent Infringement
Article
29 Aug 2024
JAMP Launches Novel Competition Complaint Alleging Janssen Abused Its Dominance Over Stelara (Ustekinumab)
Article
22 Aug 2022
Ontario Court Of Appeal Dismisses Apotex's Novel Patent Damages Appeal
Article
01 Jun 2022
AI And Patent Law: Can AI Be An "Inventor"?
Article
05 May 2022
The Diaper Wars: Angelcare And Playtex Fight Munchkin In Patent Infringement Lawsuit
Article
16 Mar 2021
Ontario Court Dismisses Apotex Patent Damages Case Grounded In 400 Year Old Statute Of Monopolies